[CRMD] CorMedix Inc


Type of security: Stock

Sector: Health Care

Industry: Major Pharmaceuticals

Market Capitalization:

Exchange: AMEX

The data is delayed by 15 minutes.


Price: 1.75 Change: 0 (0%)
Ext. hours: Change: 0 (0%)

chart CRMD

Refresh chart

Strongest Trends Summary For CRMD

CRMD is in the medium-term down -34% below S&P in 1 year. In the long-term up 1917% in 3 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart


Description: CorMedix Inc., a development-stage pharmaceutical and medical device company, intends to in-license, develop, and commercialize therapeutic products for the treatment of cardiorenal and infectious diseases. The company?s product candidates include CRMD003 (Neutrolin) and CRMD004, an antimicrobial/antifungal and anticoagulant combination in liquid and gel formulations used for the prevention of catheter-related blood stream infections and maintenance of catheter patency in hemodialysis patients. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix Inc. in January 2007. CorMedix Inc. was founded in 2006 and is based in Bridgewater, New Jersey.

Fundamental Ratios
Shares Outstanding EPS EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters -22.5% Sales Growth - Q/Q-63.53% P/E
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA-94.73% ROE-121.62% ROI
Current Ratio4.57 Quick Ratio4.35 Long Term Debt/Equity Debt Ratio0.28
Gross Margin-83.65% Operating Margin-5512.02% Net Profit Margin-4441.35% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities6.83 M Cash From Investing Activities-10 K Cash From Operating Activities-2.35 M Gross Profit10 K
Net Profit-5.5 M Operating Profit-5.5 M Total Assets9.75 M Total Current Assets9.69 M
Total Current Liabilities2.12 M Total Debt Total Liabilities2.16 M Total Revenue30 K
Technical Data
High 52 week13.25 Low 52 week0.93 Last close6.43 Last change-4.32%
RSI63.08 Average true range0.48 Beta0.71 Volume213.35 K
Simple moving average 20 days12.39% Simple moving average 50 days2.27% Simple moving average 200 days-18.16%
Performance Data
Performance Week22.71% Performance Month4.89% Performance Quart-21.01% Performance Half-8.14%
Performance Year435.83% Performance Year-to-date398.45% Volatility daily5.24% Volatility weekly11.71%
Volatility monthly23.99% Volatility yearly83.11% Relative Volume420.72% Average Volume261.45 K
New High New Low


2020-05-29 21:54:51 | Edited Transcript of CRMD earnings conference call or presentation 11-May-20 8:30pm GMT

2020-05-27 11:41:53 | Is CorMedix Inc. CRMD A Good Stock To Buy?

2020-05-21 12:00:04 | CorMedix CRMD Moves to Buy: Rationale Behind the Upgrade

2020-05-17 08:48:04 | Analyst Forecasts Just Got A Whole Lot More Bearish On CorMedix Inc. NYSEMKT:CRMD

2020-05-11 19:35:11 | CorMedix CRMD Reports Q1 Loss, Misses Revenue Estimates

2020-05-11 16:10:10 | CorMedix Inc. Reports First Quarter 2020 Financial Results and Provides Business Update

2020-05-11 08:30:10 | CorMedix Inc. Announces Appointment of Chief Financial Officer

2020-05-06 08:30:10 | CorMedix Hosting KOL Call on Antimicrobial Resistance, Catheter-Related Bloodstream Infections CRBSIs, and the Potential for Neutrolin®

2020-05-04 09:00:10 | CorMedix Inc. to Report First Quarter 2020 Financial Results and Provide a Corporate Update on May 11

2020-04-23 08:15:10 | CorMedix Inc. Announces Contract Extension of Jack Armstrong as Executive Vice President and Head of Technical Operations

2020-04-22 11:50:03 | Top Ranked Momentum Stocks to Buy for April 22nd

2020-04-22 08:00:10 | CorMedix Completes Sale of $5.5 Million of NOL Tax Benefits through New Jersey Technology Business Tax Certificate Transfer Program

2020-04-14 11:52:03 | Will CorMedix Continue to Surge Higher?

2020-03-30 11:11:55 | Edited Transcript of CRMD earnings conference call or presentation 16-Mar-20 8:30pm GMT

2020-03-20 06:32:14 | CorMedix, Inc. NYSEMKT:CRMD Just Reported Earnings, And Analysts Cut Their Target Price

2020-03-19 10:40:02 | Editas Medicine EDIT Catches Eye: Stock Jumps 9%

2020-03-19 07:19:07 | What Did CorMedix, Inc.'s NYSEMKT:CRMD CEO Take Home Last Year?

2020-03-16 17:55:09 | CorMedix CRMD Reports Q4 Loss, Misses Revenue Estimates


2020-03-16 14:30:00 | CorMedix, Inc. to Host Earnings Call

2020-03-06 08:15:10 | CorMedix Inc. to Report Fourth Quarter 2019 Financial Results and Provide a Corporate Update on March 16

2020-03-05 12:30:05 | Earnings Preview: CorMedix CRMD Q4 Earnings Expected to Decline

2020-02-03 16:19:11 | CorMedix Approved to Sell $5.5 Million of NOL Tax Benefits Through the New Jersey Economic Development Authority Program

2020-02-03 08:15:10 | CorMedix Inc. Announces FDA Grant of Rolling Review of Neutrolin® New Drug Application

2020-02-03 06:58:59 | Investors Who Bought CorMedix NYSEMKT:CRMD Shares Five Years Ago Are Now Down 59%

2019-12-20 10:56:25 | Hedge Funds Have Never Been This Bullish On CorMedix Inc. CRMD

2019-12-20 06:00:12 | Trade Alert: The Independent Director Of CorMedix, Inc. NYSEMKT:CRMD, Mehmood Khan, Has Just Spent US$112k Buying Shares

2019-12-08 08:44:39 | Companies Like CorMedix NYSEMKT:CRMD Are In A Position To Invest In Growth

2019-11-15 05:12:20 | Edited Transcript of CRMD earnings conference call or presentation 14-Nov-19 9:30pm GMT

2019-11-14 17:35:10 | CorMedix CRMD Reports Q3 Loss, Misses Revenue Estimates

2019-11-14 16:05:00 | CorMedix Inc. Reports Third Quarter 2019 Financial Results and Provides Business Update

2019-11-07 08:00:00 | CorMedix Inc. to Report Third Quarter 2019 Financial Results and Provide a Corporate Update on November 14

2019-11-06 10:30:03 | CorMedix CRMD May Report Negative Earnings: Know the Trend Ahead of Q3 Release

2019-11-06 08:15:00 | CorMedix Inc. Announces a Change to its Senior Leadership

2019-10-24 07:55:22 | Have Insiders Been Buying CorMedix, Inc. NYSEMKT:CRMD Shares This Year?

2019-10-16 08:15:00 | CorMedix Completes Successful CMC Interaction with the FDA

2019-09-26 16:30:00 | CorMedix Inc. to Present at the Cantor 2019 Global Healthcare Conference

2019-09-26 08:15:00 | CorMedix Inc. Announces Exercises of Outstanding Warrants

2019-09-24 19:14:01 | Biggest Hedge Fund Buys of September

2019-09-18 10:17:01 | Should You Worry About CorMedix, Inc.'s NYSEMKT:CRMD CEO Pay?

2019-09-03 16:30:00 | CorMedix Inc. to Present at the H.C. Wainwright 21st Annual Global Investment Conference

2019-08-14 19:21:53 | CorMedix Inc. Announces Exchange Agreement With Its Largest Investor

2019-08-14 15:49:54 | Edited Transcript of CRMD earnings conference call or presentation 13-Aug-19 8:30pm GMT

2019-08-13 17:45:09 | CorMedix CRMD Reports Q2 Loss, Misses Revenue Estimates

2019-08-13 16:05:00 | CorMedix Inc. Reports Second Quarter and Six Month 2019 Financial Results and Provides Business Update

2019-08-13 13:47:22 | Is CorMedix NYSEMKT:CRMD Weighed On By Its Debt Load?

2019-08-06 10:30:02 | CorMedix CRMD May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

2019-08-01 08:30:00 | CorMedix Inc. to Report Second Quarter 2019 Financial Results and Provide a Corporate Update on August 13

2019-07-31 11:28:05 | 7 A-Rated Stocks Under $10

2019-07-17 08:15:00 | CorMedix Presents at FDA Public Meeting on the Limited Population Pathway for Antibacterial and Antifungal Drugs